Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006361 · ClinicalTrials.gov registry record · Phase 2
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00006361: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00006361 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006361, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: SU5416 may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have advanced or recurrent cancer of the head and neck.
Interventions
- DRUG semaxanib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-12 |
| Phase | Phase 2 |
What the finished NCT00006361 record still lists
NCT00006361 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which semaxanib is the first listed.
NCT00006361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006361 about?
NCT00006361 is a clinical study titled "SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck". RATIONALE: SU5416 may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have advanced or recurrent cancer of the head and neck.
What is the current status of trial NCT00006361?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-12.
What interventions are being tested in trial NCT00006361?
The interventions under investigation include: semaxanib (DRUG).
Who is sponsoring clinical trial NCT00006361?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia